Shanghai Haohai Biological Technology Co., Ltd. Provides Earnings Guidance for the Six-Months Ended 30 June 2020
August 14, 2020 at 03:25 pm IST
Share
Shanghai Haohai Biological Technology Co., Ltd. provided earnings guidance for the six-months ended 30 June 2020. For the period, the company expects that the Group would record an unaudited net profit attributable to the shareholders of the company of approximately RMB 27.5272 million during the Reporting Period (corresponding period in 2019: approximately RMB 182.5680 million), representing a decrease of approximately 85% as compared to the corresponding period in 2019; the unaudited net profit attributable to the shareholders of the Company after deducting the non-recurring profit and loss is expected to be approximately RMB 7.8299 million (corresponding period in 2019: unaudited net profit attributable to the shareholders of the Company after deducting the non-recurring profit and loss was approximately RMB 183.8932 million), representing a decrease of approximately 96% as compared to the corresponding period in 2019.
Shanghai Haohai Biological Technology Co., Ltd. is a China-based company principally engaged in biological technology-related businesses. The businesses of the Company include the manufacture and sales of biological and medical hyaluronate, the research and development of biological engineering and pharmaceutical products and the provision of related services. Its products include orthopedics products, medical aesthetics and wound care products, ophthalmology products and anti-adhesion and hemostasis products, among others. Orthopedics products include sodium hyaluronate injection, medical chitosan and medical sodium hyaluronate gel. Medical aesthetics and wound care products include recombinant human epidermal growth factor (rhEGF), among others. Ophthalmology products include ophthalmic viscoelastic devices and lubricant eye drops. Anti-adhesion and hemostasis products include medical collagen sponges, among others. The Company mainly operates businesses in Mainland China.